The paradox of overlapping micronutrient risks and benefits obligates risk/benefit analysis

Toxicology

Volumn 278, Issue 1, 2010, Pages 27-38

  Verkerk, Robert H J ^a  

^a Alliance for Natural Health   (United Kingdom)

Author keywords

Fluoride; Folate; Food supplement; Model; Overlap; Risk benefit analysis

Indexed keywords

DRINKING WATER; FLUORIDE; FOLIC ACID; NICOTINIC ACID; SELENIUM;

ARTICLE; DECISION MAKING; DIET SUPPLEMENTATION; EUROPEAN UNION; HUMAN; MINERAL INTAKE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EUROPEAN UNION; FLUORIDES; FOLIC ACID; HUMANS; MICRONUTRIENTS; MODELS, STATISTICAL; NIACIN; RISK ASSESSMENT; SELENIUM; UNITED STATES;

EID: 78149409460     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.02.011     Document Type: Article

References (132)

1. Akhundov R.A., Sultanov A.A., Gadzhily R.A., Sadykhov R.V. Psychoregulating role of nicotinamide. Biull. Eksp. Biol. Med. 1993, 115:487-491.
2. Alkhatib M.N., Holt R., Bedi R. Aesthetically objectionable fluorosis in the United Kingdom. Br. Dent. J. 2004, 197:325-328.
3. Ames B.N. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17589-17594.
4. Anderson L.A., McMillan S.A., Watson R.G., et al. Malignancy and mortality in a population-based cohort of patients with coeliac disease or "gluten sensitivity" World J. Gastroenterol. 2007, 13:146-151.
5. Antoniades C., Shirodaria C., Warrick N., et al. 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 2006, 114:1193-1201.
6. Autier P., Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 2007, 167:1730-1737.
7. Bailey S.W., Ayling J.E. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:15424-15429.
8. Baragetti I., Raselli S., Stucchi A., et al. Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration. Nephrol. Dial. Transplant. 2007, 22:3292-3297.
9. Bean W.B., Spies T.G. A study of the effects of nicotinic acid and relate pyridine and pyrazine compounds on the temperature of the skin of human beings. Am. Heart J. 1940, 20:62-76.
10. + metabolism in health and disease. Trends Biochem. Sci. 2007, 32:12-19.
11. Bender D.A. Inhibition of tryptophan-niacin metabolism by dietary leucine and by leucine and 2-oxo-isocaproate in vitro. Adv. Exp. Med. Biol. 1991, 294:501-504.
12. Block G., Jensen C.D., Norkus, et al. Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study. Nutr. J. 2007, 6:30.
13. de Bree A., van Dusseldorp M., Brouwer I.A., et al. Folate intake in Europe: recommended, actual and desired intake. Eur. J. Clin. Nutr. 1997, 51:643-660.
14. Bronstein A.C., Spyker D.A., Cantilena L.R., et al. National Poison Data System (NPDS): 25th Annual Report. Clin. Toxicol. 2008, 46:927-1057.
15. Brouwer I.A., van Dusseldorp M., West C.E., et al. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J. Nutr. 1999, 129:1135-1139.
16. Brust J.C.M. Nutrition- and alcohol-related neurologic disorders. Cecil Medicine 2007, Saunders Elsevier, Philadelphia, Chapter 443. 23rd ed. L. Goldman, D. Ausiello (Eds.).
17. Buccianti G., Raselli S., Baragetti I., et al. 5-methyltetrahydrofolate restores endothelial function in uraemic patients on convective haemodialysis. Nephrol. Dial. Transplant. 2002, 17:857-864.
18. Cagnacci A., Cannoletta M., Volpe A. High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. Eur. J. Clin. Nutr. 2009, 63:1266-1268.
19. Caruso R., Campolo J., Sedda V. Effect of homocysteine lowering by 5-methyltetrahydrofolate on redox status in hyperhomocysteinemia. J. Cardiovasc. Pharmacol. 2006, 47:549-555.
20. Chang J.C., Gutenmann W.H., Reid C.M., Lisk D.J. Selenium content of Brazil nuts from two geographic locations in Brazil. Chemosphere 1995, 30:801-802.
21. Nutrients and Epigenetics 2009, CRC Press, Boca Raton. S.-W. Choi, S. Friso (Eds.).
22. Chunhieng T., Pétritis K., Elfakir C., et al. Study of selenium distribution in the protein fractions of the Brazil nut, Bertholletia excelsa. J. Agric. Food Chem. 2004, 52:4318-4322.
23. Clarkson J., McLoughlin J., O'Hickey S. Water fluoridation in Ireland-a success story. J. Dent. Res. 2003, 82:334-337.
24. Coppens P., da Silva M.F., Pettman S. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety. Toxicology 2006, 221:59-74.
25. Dean H.T. Endemic fluorosis and its relation to dental caries. Pub. Health Rep. 1938, 53:1443-1452.
26. Dean H.T. Fluorine and dental caries. Am. Orthod. Oral Surg. 1947, 33:B49-B67.
27. Dean H.T., Arnold F.A., Elvove E. Domestic water and dental caries. Pub. Health Rep. 1942, 57:1155-1179.
28. DeHaan L.R., Van Tassel D.L., Cox T.S. Perennial grain crops: a synthesis of ecology and plant breeding. Renew. Agr. Food Syst. 2005, 20:5-14.
29. Devlin A.M., Ling E.H., Peerson J.M., et al. Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Human Mol. Gen. 2000, 9:2837-2844.
30. Domke, A., Großklaus, R., Niemann, B., et al., 2005. Use of Vitamins in Foods, Part I/Use of Minerals in Foods, Part II, Toxicological and nutritional-physiological aspects. Bundesinstitut für Risikobewertung (Federal Institute for Risk Assessment), Berlin.
31. Ebbing M., Bønaa K.H., Nygård O. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 2009, 302:2119-2126.
32. Edwards M., Macpherson L.M., Simmons D.R., et al. An assessment of teenagers' perceptions of dental fluorosis using digital simulation and web-based testing. Community Dent. Oral Epidemiol. 2005, 33:298-306.
33. EFSA Tolerable Upper Intake Levels for Vitamins and Minerals. February 2006 2006, European Food Safety Authority, Parma, Italy.
34. EFSA, 2007. Risk-Benefit Analysis of Foods: Methods and Approaches. EFSA Scientific Colloquium Summary Report, 13-14 July 2007, Parma, Italy. 2007. European Food Safety Authority, Parma.
35. EHPM/ERNA, 2004. Vitamin and Mineral Supplements: A Risk Management Model. European Federation Association of Health Product Manufacturers (EHPM) and European Responsible Nutrition Alliance (ERNA), Brussels.
36. El-Bayoumy K. The negative results of the SELECT study do not necessarily discredit the selenium-cancer prevention hypothesis. Nutr. Cancer 2009, 61:285-286.
37. EVM, 2003. Safe Upper levels for Vitamins and Minerals. Expert Group on Vitamins and Minerals, Food Standards Agency, London.
38. Fairfield K.M., Fletcher R.H. Vitamins for chronic disease prevention in adults: scientific review. JAMA 2002, 287:3116-3126.
39. FAO/WHO, 2006. A Model for Establishing Upper Levels of Intake for Nutrients and Related Substances. Report of a joint FAO/WHO technical workshop 2005. World Health Organization, Rome.
40. Featherstone J.D. The caries balance: the basis for caries management by risk assessment. Oral Health Prev. Dent. 2004, 2:259-264.
41. Fletcher R.H., Fairfield K.M. Vitamins for chronic disease prevention in adults: clinical applications. JAMA 2002, 287:3127-3129.
42. Goldberg R.B., Jacobson T.A. Effects of niacin on glucose control in patients with dyslipidemia. Mayo Clin. Proc. 2008, 83:470-478.
43. Gonzalez-Gross M., Prinz-Langenohl R., Pietrzik K. Folate status in Germany 1997-2000. Int. J. Vit. Nutr. Res. 2002, 72:351-359.
44. Gregory J.F. Case study: folate bioavailability. J. Nutr. 2001, 131:1376S-1382S.
45. Gutteridge D.H., Stewart G.O., Prince R.L., et al. A randomized trial of sodium fluoride (60mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures. Osteoporos. Int. 2002, 13:158-170.
46. Hannon-Fletcher M.P., Armstrong N.C., Scott J.M., et al. Determining bioavailability of food folates in a controlled intervention study. Am. J. Clin. Nutr. 2004, 80:911-918.
47. Haguenauer D., Welch V., Shea B., et al. Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis. Osteoporos. Int. 2000, 11:727-738.
48. Hathcock J.N., Azzi A., Blumberg J., et al. Vitamins E and C are safe across a broad range of intakes. Am. J. Clin. Nutr. 2005, 81:736-745.
49. Hathcock J.N., Shao A., Vieth R., Heaney R. Risk assessment for vitamin D. Am. J. Clin. Nutr. 2007, 85:6-18.
50. Heller K.E., Eklund S.A., Burt B.A. Dental caries and dental fluorosis at varying water fluoride concentrations. J. Public Health Dent. 1997, 57:136-143.
51. Heseker H.B., Mason J.B., Selhub J., et al. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid. Br. J. Nutr. 2008, 102:173-180.
52. Horwitt M.K., Harper A.E., Henderson L.V.M. Niacin-tryptophan relationships for evaluating niacin equivalents. Am. J. Clin. Nutr. 1981, 34:423-427.
53. Hotamisligil G.S., Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat. Rev. Immunol. 2008, 8:923-934.
54. Hubner R.A., Houlston R.S. Folate and colorectal cancer prevention. Br. J. Cancer 2009, 100:233-239.
55. IOM Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride 1997, Institute of Medicine. National Academies Press, Washington, DC.
56. IOM Dietary Reference Intakes: A Risk Assessment Model for Establishing Upper Intake Levels for Nutrients 1998, Institute of Medicine. National Academies Press, Washington, DC.
57. IOM Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate 2005, Food and Nutrition Board, Institute of Medicine, National Academies Press, Washington, DC.
58. Jessup C.M., Bohannan B.J.M. The shape of an ecological trade-off varies with environment. Ecol. Lett. 2008, 11:947-959.
59. Johnston C.S., Retrum K.R., Srilakshmi J.C. Antihistamine effects and complications of supplemental vitamin C. J. Am. Diet. Assoc. 1992, 92:988-989.
60. Kamanna V.S., Kashyap M.L. New findings indicate that niacin directly and noncompetitively inhibits hepatocyte diacylglycerol acyltransferase-2, a key enzyme for TG synthesis. Am. J. Cardiol. 2008, 17(101):20B-26B.
61. Kamanna V.S., Ganji S.H., Kashyap M.L. The mechanism and mitigation of niacin-induced flushing. Int. J. Clin. Pract. 2009, 63:1369-1377.
62. Keenan J.M., Fontaine P.L., Wenz J.B., et al. Niacin revisited. A randomized, controlled trial of wax-matrix sustained-release niacin in hypercholesterolemia. Arch. Intern. Med. 1991, 151:1424-1432.
63. Kimball S., Fuleihan Gel-H., Vieth R. Vitamin D: a growing perspective. Crit. Rev. Clin. Lab. Sci. 2008, 45:339-414.
64. Knip M., Douek I.F., Moore W.P., et al. Safety of high-dose nicotinamide: a review. Diabetologia 2000, 43:1337-1345. European Nicotinamide Diabetes Intervention Trial Group.
65. Knopp R.H., Ginsberg J., Albers J.J., et al. Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin. Metabolism 1985, 34:642-650.
66. Krieger I., Statter M. Tryptophan deficiency and picolinic acid: effect on zinc metabolism and clinical manifestations of pellagra. Am. J. Clin. Nutr. 1987, 46:511-517.
67. Kristal A.R., Lippman S.M. Nutritional prevention of cancer: new directions for an increasingly complex challenge. J. Natl. Cancer Inst. 2009, 101:363-365.
68. Kryukov G.V., Castellano S., Novoselov S.V., et al. Characterization of mammalian selenoproteomes. Science 2003, 300:1439-1443.
69. Levy S.M. Review of fluoride exposures and ingestion. Community Dent. Oral Epidemiol. 1994, 22:173-180.
70. Lippman S.M., Klein E.A., Goodman P.J., et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009, 301:39-51.
71. Llena Puy C., Forner Navarro L. Evidence concerning the medical management of caries. Med. Oral Patol. Oral Cir. Bucal. 2008, 13:E325-E330.
72. Loesche W.J. Role of Streptococcus mutans in human dental decay. Microbiol. Rev. 1986, 50:353-380.
73. Lohi S., Mustalahti K., Kaukinen, et al. Increasing prevalence of coeliac disease over time. Aliment. Pharmacol. Ther. 2007, 26:1217-1225.
74. Luke J. Fluoride deposition in the aged human pineal gland. Caries Res. 2001, 35:125-128.
75. Maciejewski-Lenoir D., Richman J.G., Hakak Y., et al. Langerhans cells release prostaglandin D2 in response to nicotinic acid. J. Invest. Dermatol. 2006, 126:2637-2646.
76. Macpherson L.M., Conway D.I., Gilmour W.H., et al. Photographic assessment of fluorosis in children from naturally fluoridated Kungsbacka and non-fluoridated Halmstad, Sweden. Acta Odontol. Scand. 2007, 65:149-155.
77. Mager A., Orvin K., Koren-Morag N., et al. Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease. Am. J. Cardiol. 2009, 104:745-749.
78. Margis R., Dunand C., Teixeira F.K., Margis-Pinheiro M. Glutathione peroxidase family-an evolutionary overview. FEBS J. 2008, 275:3959-3970.
79. Folate and Human Development 2002, Humana Press, Totowa, NJ. E.J. Massaro, J.M. Rogers (Eds.).
80. McDonagh, M., Whiting, P., Bradley, M., et al., 2000. Fluoridation of Drinking Water: a systematic review of its efficacy and safety. CRD Report (18). NHS Centre for Reviews and Dissemination, York, UK.
81. McNulty H., Pentieva K., Hoey L., Ward M. Homocysteine, B-vitamins and CVD. Proc. Nutr. Soc. 2008, 67:232-237.
82. Mead P.S., Slutsker L., Dietz V., et al. Food-related illness and death in the United States. Emerg. Infect. Dis. 1999, 5:607-625.
83. Metelitsina T.I., Grunwald J.E., DuPont J.C., Ying G.S. Effect of niacin on the choroidal circulation of patients with age related macular degeneration. Br. J. Ophthalmol. 2004, 88:1568-1572.
84. McKenney J.M.F., Proctor J.D., Harris S.F., Chinchilli V.M. A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hyper-cholesterolemic patients. JAMA 1994, 271:672-677.
85. McNaughton S.A., Mishra G.D., Paul A.A., et al. Supplement use is associated with health status and health-related behaviors in the 1946 British birth cohort. J. Nutr. 2005, 135:1782-1789.
86. Morabito N., Gaudio A., Lasco A., et al. Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis. Osteoporos. Int. 2003, 14:500-506.
87. Mousny M., Omelon S., Wise L. Fluoride effects on bone formation and mineralization are influenced by genetics. Bone 2008, 43:1067-1074.
88. Mozaffarian D., Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006, 296:1885-1899.
89. NRC (National Research Council, US) Fluoride in Drinking Water: A Scientific Review of EPA's Standards 2006, National Academies Press, Washington, DC.
90. O'Keefe J.H., Gheewala N.M., O'Keefe J.O. Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J. Am. Coll. Cardiol. 2008, 51:249-255.
91. Olivieri O., Girelli D., Stanzial A.M., et al. Selenium, zinc, and thyroid hormones in healthy subjects: low T3/T4 ratio in the elderly is related to impaired selenium status. Biol. Trace Elem. Res. 1996, 51:31-41.
92. Parnell C., Whelton H., O'Mullane D. Water fluoridation. Eur. Arch. Paediatr. Dent. 2009, 10:141-148.
93. Prinz-Langenohl R., Brämswig S., Tobolski O., et al. [6S]-5 methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C→T polymorphism of methylenetetrahydrofolate reductase. Br. J. Pharmacol. 2009, 158:2014-2021.
94. Rader J.I., Calvert R.J., Hathcock J.N. Hepatic toxicity of unmodified and time-release preparations of niacin. Am. J. Med. 1992, 92:77-81.
95. Rayman M.P. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc. Nutr. Soc. 2005, 64:527-542.
96. Rayman M.P., Thompson A.J., Bekaert B., et al. Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom. Am. J. Clin. Nutr. 2008, 87:370-378.
97. Reinert A., Rohrmann S., Becker N., Linseisen J. Lifestyle and diet in people using dietary supplements: a German cohort study. Eur. J. Nutr. 2007, 46:165-173.
98. Renwick A.G., Walker R. Risk assessment of micronutrients. Toxicol. Lett. 2008, 180:123-130.
99. Renwick A.G., Flynn A., Fletcher R.J., et al. Risk-benefit analysis of micronutrients. Food Chem. Toxicol. 2004, 42:1903-1922.
100. Ronco A.M., Llanos M., Tamayo D., Hirsch S. 5-methyltetrahydrofolic acid stimulates endothelin-1 production in low density lipoprotein-treated human endothelial cells. Nutr. Metab. Cardiovasc. Dis. 2007, 17:188-194.
101. Rozier R.G. Epidemiologic indices for measuring the clinical manifestations of dental fluorosis: overview and critique. Adv. Dent. Res. 1994, 8:39-55.
102. SCF Guidelines of the Scientific Committee on Food for the Development of Tolerable Upper Intake Levels for Vitamins and Minerals 2000, Scientific Committee on Food, European Commission, Brussels.
103. SCF Opinion of the Scientific Committee on Food on the revision of reference values for nutrition labelling. SCF/CS/NUT/GEN/18 Final, 6 March 2003 2003, European Commission, Brussels.
104. Schectman G., Hiatt J. Dose-response characteristics of cholesterol-lowering drug therapies: implications for treatment. Ann. Intern. Med. 1996, 125:990-1000.
105. Schneider M., Förster H., Boersma A. Mitochondrial glutathione peroxidase 4 disruption causes male infertility. FASEB J. 2009, 23:3233-3242.
106. Schrauzer G.N. RE: lessons from the selenium and vitamin E cancer prevention trial (SELECT). Crit. Rev. Biotechnol. 2009, 29:81.
107. Sebrell W.H., Butler R.E. A reaction to the oral administration of nicotinic acid. J. Am. Med. Assoc. 1938, 111:2286-2287.
108. Skeie G., Braaten T., Hjartåker A., et al. Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study. Eur. J. Clin. Nutr. 2009, 63:S226-S238.
109. Smith K.M., Sahyoun N.R. Fish consumption: recommendations versus advisories, can they be reconciled?. Nutr. Rev. 2005, 63:39-46.
110. Spies T.D., Bean W.B., Stone R.E. The treatment of subclinical and classic pellagra. J. Am. Med. Assoc. 1938, 111:584-592.
111. Sood A., Arora R. Vitamin D deficiency and its correlations with increased cardiovascular incidences. Am. J. Ther. 2009, 10.1097/MJT.0b013e31819e9e88.
112. Stern R.H., Spence J.D., Freeman D.J., Parbtani A. Tolerance to nicotinic acid flushing. Clin. Pharmacol. Ther. 1991, 50:66-70.
113. Swagerty D.L., Walling A.D., Klein R.M. Lactose intolerance. Am. Fam. Physician 2002, 65:1845-1850.
114. Tan J., Zhu W., Wang W., et al. Selenium in soil and endemic diseases in China. Sci. Total Environ. 2002, 284:227-235.
115. Thompson L.J., Proctor R.C. Depressive and anxiety reactions treated with nicotinic acid and phenobarbital. N. C. Med. J. 1953, 14:420-426.
116. Thomson C.D. Assessment of requirements for selenium and adequacy of selenium status: a review. Eur. J. Clin. Nutr. 2004, 58:391-402.
117. Thomson C.D., Chisholm A., McLachlan S.K., Campbell J.M. Brazil nuts: an effective way to improve selenium status. Am. J. Clin. Nutr. 2008, 87:379-384.
118. Tinggi U. Essentiality and toxicity of selenium and its status in Australia: a review. Toxicol. Lett. 2003, 137:103-110.
119. Troen A.M., Mitchell B., Sorensen B., et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J. Nutr. 2006, 136:189-194.
120. Verkerk R.H.J., Hickey S. A critique of prevailing approaches to nutrient risk analysis pertaining to food supplements with specific reference to the European Union. Toxicology 2010, 278:17-26.
121. Vieira A.P., Hanocock R., Eggertsson H., et al. Tooth quality in dental fluorosis genetic and environmental factors. Calcif. Tissue Int. 2005, 76:17-25.
122. Vieth R. Vitamin D toxicity, policy, and science. J. Bone Miner. Res. 2007, 22:V64-V68.
123. Warren J.J., Levy S.M., Broffitt B. Considerations on optimal fluoride intake using dental fluorosis and dental caries outcomes-a longitudinal study. J. Public Health Dent. 2009, 69:111-115.
124. Waters D.J., Shen S., Glickman L.T., et al. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model. Carcinogenesis 2005, 26:1256-1262.
125. Whelton E., Crowley D., O'Mullane, et al. North South Survey of Children's Oral Health 2002, WHO Collaborating Centre for Oral Health Services Research University College Cork, Ireland.
126. Wilkinson J.F., Israels M.C. Pteroylpolyglutamic acids in the treatment of pernicious anaemia. Lancet 1949, 2:689-691.
127. Winkels R.M., Brouwer I.A., Siebelink E., et al. Bioavailability of food folates is 80% of that of folic acid. Am. J. Clin. Nutr. 2007, 85:465-473.
128. Wurtz T., Houari S., Mauro N., et al. Fluoride at non-toxic dose affects odontoblast gene expression in vitro. Toxicology 2008, 249:26-34.
129. Yang G.Q., Wang S.Z., Zhou R.H., Sun S.Z. Endemic selenium intoxication of humans in China. Am. J. Clin. Nutr. 1983, 37:872-881.
130. Yang G., Yin S., Zhou R., et al. Studies of safe maximal daily selenium intake in a seleniferous area in China. Part II. J. Trace Elem. Electrol. Health Dis. 1989, 3:123-130.
131. Zeng H. Selenium as an essential micronutrient: roles in cell cycle and apoptosis. Molecules 2009, 14:1263-1278.
132. Zero D.T. Sugars-the arch criminal?. Caries Res. 2004, 38:277-285.